Tarsus Pharmaceuticals, Inc. TARS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
31.54UNCH (UNCH)
Volume
517
Close
31.54quote price arrow up+0.93 (+3.04%)
Volume
29,519
52 week range
15.32 - 63.69

...

Loading . . .

KEY STATS

  • Open30.05
  • Day High32.46
  • Day Low29.10
  • Prev Close30.61
  • 52 Week High63.69
  • 52 Week High Date12/18/20
  • 52 Week Low15.32
  • 52 Week Low Date10/16/20
  • Market Cap640.89M
  • Shares Out20.32M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-126.72
  • Fwd P/E (NTM)-11.96
  • EBITDA (MRQ)-7.039M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Tarsus Pharmaceuticals, Inc. News

There is no recent news for this security.

Latest TARS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Tarsus Pharmaceuticals Inc. is a late clinical-stage biopharmaceutical company. The Company if focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. Its lead product candidate, TP-03, is a novel therapeutic being developed for the treatment of blepharitis caused by the infestation of Demodex mites (Demodex blepharitis). It is developing TP-03 as an eye drop. It is also focused on developing additional clinical-stage...
Address
15440 Laguna Canyon Road
Irvine, CA
92618
United States